RenovoRx, Inc. 8-K

What Happened
RenovoRx, Inc. announced its financial results for the quarter ended March 31, 2026 in a press release issued May 14, 2026. The company filed the press release as Exhibit 99.1 to Form 8‑K (Item 2.02 — Results of Operations and Financial Condition), which is incorporated by reference in the 8‑K.

Key Details

• Filing date: May 14, 2026 (Form 8‑K, Item 2.02).
• Period reported: Quarter ended March 31, 2026.
• Disclosure format: Press release attached as Exhibit 99.1 to the 8‑K.
• The 8‑K notifies investors the company has published its latest quarterly results (earnings, revenue and related financial condition) — see Exhibit 99.1 for the detailed figures and management commentary.

Why It Matters
This 8‑K delivers RenovoRx’s latest quarterly financial update. Retail investors should review the attached press release (Exhibit 99.1) to see the company’s reported revenue, net income or loss, cash position and any management commentary or forward-looking statements. Those figures are the material data points that could affect the company’s short‑term valuation and investor decisions.